Lantheus Corp (LNTH): Price-to-Revenue Coefficient

Corporate company logo of Lantheus Medical Imaging (LNTH)

Revenue dynamics from Pylarify and B2B sales are creating volatility that, when reviewing the P/S history on GURU.Markets, can be correlated with market expectations. The value of 4.20 represents the current metric. Stability is provided by an impeccable reputation among physicians and exclusive rights to radiopharmaceuticals, which create a robust defensive barrier for the business margins of Lantheus Holdings, Inc. (LNTH).

LNTH: lantheus.com P/S Multiple 07/04/2022 - 11/17/2026

Metric breakdowns and analytics for Lantheus Holdings, Inc. (LNTH)

- stock value and consensus price forecast:
General company analysis:Lantheus (LNTH)
Mass-produced product of Lantheus Corp

The P/S ratio compares the market value of Lantheus Holdings, Inc. (LNTH) to its annual revenue, allowing for an assessment of the asset's fair value regardless of current debt loads or quarterly profit fluctuations. By analyzing the price-to-sales trend, an investor can separate speculative noise from the fundamental resilience of the business, which is based on the critical importance of US-based production of diagnostic agents for cardiology.